NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
There is a void in evidence-based information for making informed decisions on how to optimize care for older adults, particularly those 80 years and over. Because older adults are vastly underrepresented in clinical trials, there is a dearth of information about the appropriate use of drugs in this population. Yet older adults have higher rates of comorbidities and simultaneous use of multiple medications than the general population, and are the majority users of many medications. Additionally, age-related physiological and pathological changes, particularly for adults 80 years of age and older, can lead to significant differences in the pharmacokinetics (PK)2 and pharmacodynamics (PD)3 of a given drug compared to the general population. On August 5 and 6, 2020, the National Academies of Sciences, Engineering, and Medicine hosted a workshop titled Drug Research and Development for Adults Across the Older Age Span. The workshop was designed to examine the challenges and opportunities in drug research and development for older adult populations, explore barriers that impede safety and efficacy studies in these populations, and share lessons learned for better understanding clinical pharmacology for populations over age 65. This publication summarizes the presentation and discussion of the workshop.
Contents
- The National Academies of SCIENCES • ENGINEERING • MEDICINE
- PLANNING COMMITTEE FOR A WORKSHOP ON DRUG RESEARCH AND DEVELOPMENT FOR ADULTS ACROSS THE OLDER AGE SPAN
- FORUM ON AGING, DISABILITY, AND INDEPENDENCE
- FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION
- NATIONAL CANCER POLICY FORUM
- Reviewers
- Acknowledgments
- Acronyms and Abbreviations
- 1. Introduction
- 2. Inclusion of Older Adults in Clinical Trials: An Evolving Landscape
- 3. Overcoming Key Barriers
- 4. Alternative Study Approaches
- 5. Strategies for Engaging Older Adults in Clinical Research
- 6. Clinical Trials in the Era of COVID-19 and Beyond
- 7. Reflections and Key Takeaways
- Appendix A. References
- Appendix B. Workshop Agenda
- Appendix C. Speaker Biosketches
Suggested citation:
National Academies of Sciences, Engineering, and Medicine. 2021. Drug research and development for adults across the older age span: Proceedings of a workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/25998.
Digital Object Identifier: https://doi.org/10.17226/25998
Additional copies of this publication are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Printed in the United States of America
- NLM CatalogRelated NLM Catalog Entries
- Review Challenges and Opportunities for Precision and Personalized Nutrition: Proceedings of a Workshop[ 2022]Review Challenges and Opportunities for Precision and Personalized Nutrition: Proceedings of a WorkshopNational Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board; Food Forum, Callahan EA. 2022 Apr 15
- Review Sex Differences in Brain Disorders: Emerging Transcriptomic Evidence: Proceedings of a Workshop[ 2021]Review Sex Differences in Brain Disorders: Emerging Transcriptomic Evidence: Proceedings of a WorkshopNational Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders, Stroud C, Norris SMP, Bain L. 2021 Mar 10
- Pharmacokinetic and pharmacodynamic alterations in the geriatric patient.[Consult Pharm. 2008]Pharmacokinetic and pharmacodynamic alterations in the geriatric patient.Delafuente JC. Consult Pharm. 2008 Apr; 23(4):324-34.
- Review Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force[ 2018]Review Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task ForceLeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. 2018 Sep
- Review Health Literacy and Older Adults: Reshaping the Landscape: Proceedings of a Workshop[ 2018]Review Health Literacy and Older Adults: Reshaping the Landscape: Proceedings of a WorkshopNational Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Health Literacy. 2018 Oct 22
- Drug Research and Development for Adults Across the Older Age SpanDrug Research and Development for Adults Across the Older Age Span
Your browsing activity is empty.
Activity recording is turned off.
See more...